Occidental Petroleum Corporation vs Vaxcyte Inc. Common Stock — how do they compare? Occidental Petroleum Corporation trades at $61.79 (market cap $61.63B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Occidental Petroleum Corporation is far larger — about 5.9× Vaxcyte Inc. Common Stock's market cap, and Occidental Petroleum Corporation pays a 1.82% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Occidental Petroleum Corporation for 92 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| OXY | PCVX | |
|---|---|---|
Market Cap | $61.63B | $10.51B |
Volume | 9,180,422 | 2,644,694 |
Sector | Energy | Health |
52-Week High | $66.24 | $73.82 |
52-Week Low | $38.92 | $40.32 |
Typical Hold Time | 92 Days | 0 Days |
Enterprise Value | $80.39B | $9.14B |
Dividend Yield | 1.82% | — |
Signals from Pluang's Aura AI — not financial advice
Occidental Petroleum (OXY) trades at $61.41, up 0.46% with strong technical momentum and bullish moving average signals. The company demonstrates robust profitability with 30.32% net income margin and 21.46% ROE, though revenue has declined from $36.6B in 2022 to $21.6B in 2025. Recent earnings beats and a $71.40 consensus price target suggest upside potential, supported by Goldman Sachs' October 1 upgrade citing cash flow targets and debt reduction plans.
OXY presents a compelling value opportunity with attractive valuation multiples (P/E 18.19, EV/EBITDA 5.66) and strong analyst support (52% buy rating). Key risks include oil price volatility and declining revenue trends, while catalysts include upcoming Q3 earnings and continued operational efficiency improvements. The stock's technical strength and fundamental value create favorable risk-reward dynamics for energy sector exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →